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INTRODUCTION
Immunoglobulin G (IgG) is the most common immuno-
globulin, accounting for approximately 75% of all immuno-
globulins in the blood.1 IgG is further subdivided into the sub-
types IgG1, IgG2, IgG3, and IgG4,2 among which IgG4 accounts 
for approximately 2–5% of all IgG.2 Unlike the other IgG sub-
types, IgG4 is known to have non-inflammatory properties.3 It 
forms a bispecific monovalent antibody through Fab arm ex-
change,4 exhibits a limited ability to cross-link with allergens, 
and cannot form immune complexes.3,5 Further, it has a dis-
rupted C1q-binding site and, thus, cannot activate comple-
ment pathways.6 It also has reduced effector function relative 
to other IgG subtypes.4 Furthermore, specific IgG4 (sIgG4) 
competes with specific IgE (sIgE) to prevent mast cell and ba-
sophil degranulation and is known as a blocking antibody.3 
These unique characteristics of IgG4 make it favorable for the 
assessment of immunotherapy efficacy: sIgG4 levels are in-
creased following immunotherapy and then decrease after 
termination of immunotherapy.3,7 In addition, sIgE/sIgG4 ra-
tios for food allergens, such as egg, milk, and peanut, are asso-
ciated with the prediction of immune tolerance to these aller-
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Purpose: Specific IgG4 (sIgG4) increases with allergen specific immunotherapy and may reflect a state of immune tolerance in 
food allergy. While ImmunoCAP® has been widely used to measure sIgG4 to a single allergen, PROTIATM Specific IgG4® has been 
designed as a multiplex assay for measuring sIgG4. This study sought to validate this assay in comparison to ImmunoCAP®. 
Materials and Methods: Measurements of sIgG4 were compared between PROTIATM Specific IgG4® and ImmunoCAP® using 
sera from 519 allergy patients (asthma: 114, allergic rhinitis: 318, food allergy: 146) with 731 paired tests. sIgG4 was measured 
against nine inhalant allergens (Dermatophagoides pteronyssinus, Dermatophagoides farinae, cat dander, dog dander, birch pol-
len, oak pollen, ragweed pollen, mugwort pollen, and Alternaria alternata spores) and nine food allergens (egg white, casein, 
wheat, peanut, walnut, crab, shrimp, apple, and peach).  
Results: PROTIATM Specific IgG4® showed 95.6% agreement rate with ImmunoCAP® in the positivity comparison. For sIgG4 posi-
tivity to each individual allergen, an agreement rate of more than 84.8% was observed. In Cohen’s kappa analysis, these assays 
displayed substantial correlations [Cohen’s kappa coefficient (κ) ≥0.699], except for shrimp (κ=0.448). Furthermore, both assays 
displayed strong correlations in quantitative comparisons [correlation coefficients value (ρ) ≥0.8014], except for apple (ρ=0.6571, 
p=0.175). Serial dilution tests also showed consistency between the assays. 
Conclusion: PROTIATM Specific IgG4® showed high consistency with ImmunoCAP® in measuring sIgG4. This assay is applicable 
to various clinical fields, including allergen immunotherapy and food allergy.
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gens.8,9 Therefore, sIgG4 is considered as a monitoring tool of 
immunotherapy10 and an alternative to the double-blind pla-
cebo-controlled food challenge test (DBPCFC) for predict re-
mission.11 
Meanwhile, IgG4 can be harmful in some diseases. IgG4 is 
closely associated with eosinophilic esophagitis12 and is in-
volved in the immune response of factor VIII and factor IX.13,14 
These factors can be inhibited by IgG4, and this immune reac-
tion is associated with hemophilia. Moreover, IgG4 can re-
duce clinical responses to recombinant antibodies, such as 
adalimumab.15 Additionally, IgG4 is associated with parasite 
infection and IgG4-related disease.16,17 Therefore, IgG4 may be 
used as biomarkers for such pathologic conditions.
The ImmunoCAP® assay (Thermo Fisher Scientific, Uppsala, 
Sweden) has been widely used to detect sIgG4. However, Im-
munoCAP® is a singleplex assay, and the cost per allergen is 
higher than that of a multiplex assay. Recently, PROTIATM Spe-
cific IgG4® (ProteomeTech Inc., Seoul, Korea), a multiplex 
sIgG4 assay, was developed to solve this issue. It is based on 
the enzyme immunoassay technique that uses nitrocellulose 
membrane as the solid-phase for allergen immobilization and 
can quantify sIgG4 against 42 important food and inhalant al-
lergens using only 10 μL of serum (Table 1). This study aimed 




Five hundred and nineteen Korean allergy patients who visited 
the Allergy and Asthma Center of Severance Hospital for the 
diagnosis and treatment of their allergic diseases from August 
2013 to May 2019 were enrolled in this study. The demographic 
characteristics of the patients are summarized in Table 2. There 
were 310 males and 209 females. The mean age of the patients 
was 24.0±16.9 years (mean±standard deviation). Three hun-
dred and eighteen patients (61.3 %) had allergic rhinitis, 198 
(38.2%) patients had atopic dermatitis, 146 patients (28.1%) 
had food allergy, and 114 patients (22.0%) had asthma. Pa-
tients did not have other chronic diseases, including autoim-
mune diseases, cancer, chronic infections, or other immune-
related diseases. Blood samples were collected from all 
patients to perform the two diagnostic tests, PROTIATM Specific 
IgG4® and ImmunoCAP®. The total number of paired tests was 
731, and the most frequently tested allergen was Dermatopha-
goides farinae (235), followed by Dermatophagoides pteronys-
sinus (176), Alternaria alternata spores (36), walnut (33), ca-
sein (31), cat dander (30), dog dander (26), egg white (24), 
wheat (24), peanut (23), peach (17), crab (16), shrimp (16), ap-
ple (15), birch pollen (10), oak pollen (7), ragweed pollen (7), 
and mugwort pollen (5). The Severance Hospital Ethical Re-
view Board approved this study (No. 4-2017-1258), and in-
formed consent was obtained from all 519 patients.
Serum preparation and allergen selection
Five milliliters of whole blood was collected in a vacuum tube 
(Vacuette®; Greiner Bio-One GmbH, Kremsmünster, Austria) 
for serum separation via centrifugation at 3000 rpm for 5 min, 
and the supernatant was aliquoted into several round-bottom 
tubes (5-mL BD FalconTM tubes; BD Bioscience Discovery Lab-
ware, Bedford, MA, USA), and stored at -76°C until further use.
Eighteen culprit allergens were selected for measuring 
sIgG4: nine inhalant allergens (D. pteronyssinus, D. farinae, 
cat dander, dog dander, birch pollen, oak pollen, ragweed pol-
len, mugwort pollen, and Alternaria alternata spores) and 
nine food allergens (egg white, casein, wheat, peanut, walnut, 
crab, shrimp, apple, and peach).
In vitro sIgG4 measurements 
Both PROTIATM Specific IgG4® and ImmunoCAP® sIgG4 as-
says were performed according to the manufacturers’ instruc-
tions. The researcher performing the PROTIATM Specific IgG4® 
assay was blinded to the results of ImmunoCAP®. The sIgG4 
detection range of PROTIATM Specific IgG4® was 0.50–30 mg/
L, and that of ImmunoCAP® was 0.07–30 mg/L. To compare 
the agreement rate of these two assays, sIgG4 values ≥0.50 
mg/L were regarded as positive.
Table 1. Specific IgG4s That Can Be Quantified Using PROTIATM Specific 
IgG4®
Number Allergen Number Allergen
1 Dermatophagoides pteronyssinus 22 Milk
2 Dermatophagoides farinae 23 Casein
3 Cat dander 24 α-lactalbumin
4 Dog dander 25 β-lactoglobulin
5 Birch pollen 26 Codfish
6 Oak pollen 27 Mackerel
7 Grass pollen mix 28 Crab
8 Ragweed pollen 29 Shrimp
9 Mugwort pollen 30 Oyster
10 Japanese hop pollen 31 Wheat
11 Aspergillus fumigatus spores 32 Buckwheat
12 Penicillium notatum spores 33 Rice
13 Alternaria alternata spores 34 Soy bean
14 Bee venom 35 Peanut
15 Wasp venom 36 Walnut
16 Cockroach 37 Almond
17 Pork 38 Peach
18 Beef 39 Apple
19 Chicken 40 Kiwi
20 Egg yolk 41 Mango
21 Egg white 42 α-Gal
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Serial dilution test
sIgG4 levels were measured by PROTIATM Specific IgG4® using 
serial dilutions of patient sera. Sera with high IgG4 titers against 
D. pteronyssinus, D. farinae, cat dander, dog dander, birch pol-
len, or ragweed pollen were selected for this analysis. Selected 
serum samples were diluted one-, two-, four-, eight-, 16-, 32-, 
64-, and 128-fold with immunoglobulin-depleted serum.
Statistical analysis
The positivity of sIgG4 values was compared using Cohen’s 
kappa analysis. Cohen’s kappa values (κ) were categorized as 
almost perfect (0.8–1.0), substantial (0.6–0.8), moderate (0.4–
0.6), fair (0.2–0.4), or poor correlations (below 0.2).18 Pearson’s 
correlation coefficients were used for quantitative compari-
sons of house dust mite sIgG4, and Spearman’s rank coeffi-
cient was used for quantitative comparisons of sIgG4 for other 
allergens. The degrees of correlation were expressed as a 
Pearson’s correlation coefficient value (r) or Spearman’s cor-
relation coefficient value (ρ). Correlation coefficient values 
were categorized as very strong (0.90–1.00), strong (0.70–0.89), 
moderate (0.40–0.69), weak (0.10–0.39), or negligible correla-
tions (0.00–0.09).19 Because negative values cannot be com-
pared, only sIgG4 values ≥0.50 mg/L were used for quantita-
tive comparison. SPSS 25.0 (IBM Corp., Armork, NY, USA) was 
used for statistical analysis, and p<0.05 was considered statis-
tically significant.
RESULTS
Qualitative comparison between the two assays
Comparing positivity with the cut-off level of 0.50 mg/L, the 
agreement rate for all 731 paired tests was 95.6%, with at least 
equal or more than 84.8% agreement rate (walnut) being ob-
served between the two assays for each allergen (Table 3). In-
halant allergens showed high agreement rates of more than 
90%. Food allergens also showed high agreement rates of more 
than 90%, except walnut (84.8%) and shrimp (87.5%). In the 
Cohen’s kappa analysis, most inhalant allergens showed al-
most perfect correlation (κ>0.8). Dog dander showed substan-
tial correlation (κ=0.752). Most food allergens also showed al-
most perfect correlation, and walnut showed substantial 
correlation (κ=0.699). However, shrimp showed only moderate 
correlation (κ=0.448). The κ value could not be determined for 
crab because all sIgG4 titers against crab were negative. 
Quantitative comparison between the two assays
The measured sIgG4 values of 12 allergens (D. pteronyssinus, 
D. farinae, cat dander, dog dander, birch pollen, ragweed pol-
len, egg white, casein, wheat, peanut, walnut, and peach) that 
Table 2. Demographic Characteristics of the 519 Studied Subjects in Accordance with the Allergens
Allergens






ImmunoCAP sIgE Underlying disease
Positive Negative Not performed AR Asthma AD Food allergy
Dermatophagoides  
  pteronyssinus
176 112:64 25.8±10.8 158 (89.8) 4 (2.3) 14 (8.0) 164 (93.2) 32 (18.2) 105 (59.7) 12 (6.8)
Dermatophagoides  
  farinae
235 146:89 29.1±13.8 222 (94.5) 4 (1.7) 9 (3.8) 223 (94.9) 52 (22.1) 7 (3.0) 9 (3.8)
Cat dander 30 15:15 32.7±13.4 30 (100) 0 (0) 0 (0) 22 (73.3) 17 (56.7) 9 (30.0) 0 (0)
Dog dander 26 11:15 31.4±13.5 23 (88.5) 1 (3.8) 2 (7.7) 17 (65.4) 16 (61.5) 13 (50.0) 0 (0)
Birch pollen 10 8:2 19.4±7.5 9 (90.0) 1 (10.0) 0 (0) 7 (70.0) 5 (50.0) 1 (10.0) 0 (0)
Oak pollen 7 6:1 21.0±10.8 4 (57.1) 3 (42.9) 0 (0) 4 (57.1) 2 (28.6) 1 (14.3) 0 (0)
Ragweed pollen 7 4:3 45.6±10.0 6 (85.7) 1 (14.3) 0 (0) 7 (100) 3 (42.9) 1 (14.3) 0 (0)
Mugwort pollen 5 2:3 38.2±16.1 2 (40.0) 2 (40.0) 1 (20.0) 5 (100) 0 (0) 0 (0) 0 (0)
Alternaria alternata  
  spores
36 25:11 17.0±14.3 36 (100) 0 (0) 0 (0) 22 (61.1) 14 (38.9) 7 (19.4) 9 (25.0)
Egg white 24 17:7 4.8±3.8 24 (100) 0 (0) 0 (0) 3 (12.5) 3 (12.5) 12 (50.0) 21 (87.5)
Casein 31 19:12 9.3±13.3 24 (77.4) 7 (22.6) 0 (0) 2 (6.5) 5 (16.1) 18 (58.1) 28 (90.3)
Wheat 24 16:8 12.8±16.8 18 (75.0) 6 (25.0) 0 (0) 3 (12.5) 0 (0) 8 (33.3) 14 (58.3)
Peanut 23 12:11 7.5±9.2 20 (87.0) 2 (8.7) 1 (4.3) 3 (13.0) 3 (13.0) 9 (39.1) 15 (65.2)
Walnut 33 17:16 8.4±4.9 32 (97.0) 1 (3.0) 0 (0) 5 (14.7) 4 (11.8) 10 (29.4) 15 (44.1)
Crab 16 9:7 43.4±17.2 14 (87.5) 2 (12.5) 0 (0) 2 (12.5) 0 (0) 1 (6.3) 10 (62.5)
Shrimp 16 11:5 31.9±21.5 14 (87.5) 2 (12.5) 0 (0) 5 (31.3) 1 (6.3) 1 (6.3) 13 (81.3)
Apple 15 9:6 31.9±20.6 15 (100) 0 (0) 0 (0) 10 (66.7) 2 (13.3) 2 (13.3) 12 (80.0)
Peach 17 8:9 23.2±14.9 14 (82.4) 2 (11.8) 1 (5.9) 4 (23.5) 1 (5.9) 4 (23.5) 5 (29.4)
Total 731 (519 patients) 310:209 24.0±16.9 665 (90.8) 38 (5.2) 28 (3.8) 318 (61.3) 114 (22.0) 198 (38.2) 146 (28.1)
AR, allergic rhinitis; AD, atopic dermatitis.
Data are presented as number (%) unless otherwise noticed.
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were positive in both assays are shown in Fig. 1. The sIgG4 
values of other allergens that had only a few cases (oak pollen, 
mugwort pollen, Alternaria alternata spores, shrimp, and ap-
ple) are shown in Supplementary Fig. 1 (only online). The val-
ues of the two assays showed consistent tendencies, and cor-
relation analysis between the two assays also showed a 
significant correlation (Table 4). Inhalant allergens showed 
more than strong correlation (r or ρ >0.7). Food allergens also 
showed more than strong correlation, except for apple (mod-
erate, ρ=0.6571, p=0.175). Oak pollen, mugwort pollen, Alter-
naria alternata spores, crab, and shrimp could not be as-
sessed owing to very few positive pairs of results.
Serial dilution test
Each serum sample with positive sIgG4 against D. pteronyssi-
nus (12.3 mg/L), D. farinae (12.0 mg/L), cat dander (19.4 mg/
L), dog dander (7.3 mg/L), birch pollen (14.5 mg/L), and rag-
weed pollen (10.87 mg/L) was serially diluted with immuno-
globulin-depleted serum. The decreasing concentration-dilu-
tion curves for sIgG4 values are illustrated in Fig. 2. The average 
reduction rates based on the two-fold dilution for sIgG4 were 
around 50%: D. pteronyssinus (51%), D. farinae (48%), cat dan-
der (51%), dog dander (54%), birch pollen (53%), and ragweed 
pollen (50%). When values were lower than the measurable 
value, tests showing negative results were repeated.
DISCUSSION
This study is the first, to our knowledge, to validate the sIgG4 
measurement ability of PROTIATM Specific IgG4®. This assay 
showed a high agreement with ImmunoCAP® for the qualita-
tive and quantitative measurements of sIgG4. Furthermore, the 
serial dilution test confirmed the measurement consistency of 
this assay. The PROTIATM Specific IgG4® assay can simultane-
ously measure sIgG4 against 42 important allergens, and this 
assay can be performed with very small amounts of serum.
sIgG4 is widely used as a biomarker for immunotherapy,10 
and its level increases during immunotherapy. Therefore, it is 
considered as a compliance marker of immunotherapy,10 and 
because an increase in sIgG4 is associated with a beneficial ef-
fect in immunotherapy, a low sIgG4 level is a predictor of a poor 
immunotherapeutic effect.10 However, in immunotherapy with 
multiple allergens, multiple ImmunoCAP® tests are needed to 
measure the sIgG4 levels of each allergen, making the cost of 
the assay relatively high. On the contrary, a single test with 
PROTIATM Specific IgG4® can simultaneously quantify the 
sIgG4 levels of multiple allergens. This assay can measure sIgG4 
levels against allergens commonly used for immunotherapy, 
including house dust mites, birch pollen, oak pollen, ragweed 
pollen, mugwort pollen, cat dander, dog dander, Alternaria al-
ternata spores, bee venom, egg, milk, and peanut. Therefore, 
PROTIATM Specific IgG4® is appropriate for observing the prog-
ress of immunotherapy for multiple allergens. Multiple allergen 
Table 3. Qualitative Comparison of ImmunoCAP® and PROTIATM Specific IgG4®
Allergens
ImmunoCAP® PROTIATM Specific IgG4®
Agreement rate (%) κ value
Positive (n) Negative (n) Positive (n) Negative (n)
Dermatophagoides pteronyssinus 69 107 79 97 94.3 0.884†
Dermatophagoides farinae 91 144 93 142 97.4 0.946†
Cat dander 18 12 16 14 93.3 0.865†
Dog dander 21 5 21 5 92.3 0.752†
Birch pollen 5 5 5 5 100.0 1*
Oak pollen 2 5 2 5 100.0 1*
Ragweed pollen 6 1 6 1 100.0 1*
Mugwort pollen 1 4 1 4 100.0 1*
Alternaria alternata spore 1 35 1 35 100.0 1†
Egg white 12 12 12 12 100.0 1†
Casein 21 10 22 9 96.8 0.924†
Wheat 15 9 15 9 100.0 1†
Peanut 7 16 9 14 91.3 0.810†
Walnut 12 21 17 16 84.8 0.699†
Crab 0 16 0 16 100.0 N/A
Shrimp 1 15 3 13 87.5 0.448*
Apple 6 9 7 8 93.3 0.865†
Peach 11 6 10 7 94.1 0.876†
Total 299 432 319 412 95.6 0.910†
N/A, not applicable.
κ=Cohen’s kappa coefficient, κ values were categorized as almost perfect (0.8–1.0), substantial (0.6–0.8), moderate (0.4–0.6), fair (0.2–0.4), or poor correlations (<0.2). 
*p <0.05, †p <0.001.
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Fig. 1. Measured sIgG4 values for 12 allergens that were positive in both ImmunoCAP® and PROTIATM Specific IgG4®.  
Table 4. Quantitative Comparison between ImmunoCAP® and PROTIATM Specific IgG4®
Allergens Number of cases Correlation coefficient value Degree of correlation p value
Dermatophagoides pteronyssinus 69 0.9651 Very strong <0.001
Dermatophagoides farinae 89 0.9582 Very strong <0.001
Cat dander 16 0.8400 Strong <0.001
Dog dander 20 0.8014 Strong <0.001
Birch pollen 5 1.0000 Very strong 0.017
Ragweed pollen 6 0.9856 Very strong 0.006
Egg white 12 0.9441 Very strong <0.001
Casein 21 0.9494 Very strong <0.001
Wheat 15 0.8097 Strong <0.001
Peanut 7 0.9643 Very strong 0.003
Walnut 12 0.9037 Very strong <0.001
Apple 6 0.6571 Moderate 0.175
Peach 10 0.8811 Strong 0.001
Positive results in both tests were compared through correlation analysis. A sIgG4 value ≥0.50 mg/L was considered a positive result. Correlation coefficient 
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Fig. 2. Serial dilution tests performed using PROTIATM Specific IgG4®. Patient sera were diluted with immunoglobulin-depleted serum. N*: negative. Spe-
cific IgG4 <0.50 mg/L is considered a negative result. 
immunotherapy is especially popular in the US where the 
mean number of prescribed allergens is about 8.20 
sIgG4 is an important marker for food allergy immunothera-
py.21 Although it is unclear whether IgG4 is directly linked to the 
development of tolerance to food allergens,22 food allergen im-
munotherapy is often associated with an increase in sIgG4 and 
a reduction in sIgE,23 and high sIgG4 and low sIgE levels have 
been reported to be associated with food allergy tolerance.21 
Furthermore, patients with food allergy who test positive have a 
higher sIgE/sIgG4 than those who test negative during DBP-
CFC.8 Therefore, sIgG4 is used as an immune tolerance bio-
marker for food allergy.21 However, patients with food allergy 
are often sensitized to multiple allergens. Lee, et al.24 reported 
that adult patients with food allergy are allergic to more than 
two culprit food allergen, and Wang25 reported that pediatric 
patients are allergic to three to four culprit food allergens. In ad-
dition, because pollen-food allergy syndrome is often associat-
ed with pollinosis patients,26,27 sIgG4 levels of several food aller-












































1       1/2      1/4      1/8    1/16    1/32   1/64   1/128
1       1/2      1/4      1/8    1/16    1/32   1/64   1/128
1       1/2      1/4      1/8    1/16    1/32   1/64   1/128
1       1/2      1/4      1/8    1/16    1/32   1/64   1/128
1       1/2      1/4      1/8    1/16    1/32   1/64   1/128
1       1/2      1/4      1/8    1/16    1/32   1/64   1/128
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gens might need to be tested during pollen immunotherapy. 
Therefore, there is a limit in measuring sIgG4 with a singleplex 
assay. Because PROTIATM Specific IgG4® can measure 26 food 
allergens, this assay can be applied to monitor immunotherapy 
for food allergy patients with multiple culprit allergens or to 
predict the tolerance status of those patients.
Meanwhile, sIgG4 may play a vicious role in other diseases. 
sIgG4 is associated with eosinophilic esophagitis, and the level 
of tissue IgG4 correlates with the severity of eosinophilic 
esophagitis and tissue eosinophilia, suggesting the harmful 
role of sIgG4 in this disease.28,29 Identification of the culprit al-
lergen by measuring sIgE and quantifying sIgG4 levels may 
help diagnose and treat patients with eosinophilic esophagi-
tis.30 Culprit food allergens for eosinophilic esophagitis are 
usually many, including common food allergens, such as milk, 
egg, wheat, soy, and seafood.31 Identification of culprit inhalant 
allergens may also be important in eosinophilic esophagitis, 
because accompanying sensitization to inhalant allergens is 
common.32 Oral allergy syndrome can also induce eosinophil-
ic esophagitis,33 and oral immunotherapy for food and sublin-
gual immunotherapy for inhalant allergens may also cause eo-
sinophilic esophagitis.34,35 sIgG4 concentrations against these 
food and inhalant allergens can simultaneously be determined 
using PROTIATM Specific IgG4®. Therefore, this assay is poten-
tially applicable to patients with eosinophilic esophagitis.
Another disease where IgG4 may have a pathologic role is 
IgG4-related disease, which is characterized by a systemic fi-
broinflammatory condition with an elevated serum total IgG4 
level and the accumulation of IgG4-positive plasma cells in the 
affected organs.17 In general, total serum IgG4 levels are mea-
sured to diagnose IgG4-related disease.36 Culver, et al.37 also re-
ported that food sIgG4 is elevated in IgG4-related disease. 
However, the association between food sIgG4 and IgG4-related 
disease remains unknown. Therefore, the applicability of PRO-
TIATM Specific IgG4® in IgG4-related disease is uncertain.
PROTIATM Specific IgG4® may be applicable to patients with 
Crohn’s disease, for whom dietary restrictions are recom-
mended. Crohn’s disease is an inflammatory bowel disease 
primarily affecting the ileum and colon.38 Dietary restrictions 
help treat some patients with this disease.39 However, the 
complexity of dietary restrictions makes it difficult for pa-
tients. A previous study reported an improvement in symp-
toms and a reduction in the erythrocyte sedimentation rate 
among patients on a targeted exclusion diet by quantifying 
sIgG4 levels.40 Therefore, PROTIATM Specific IgG4® might be 
applied to determine which foods to restrict. Similarly, dietary 
restrictions are effective in cases of irritable bowel syndrome,41 
wherein sIgG4 levels are increased.42 Zar, et al.42 reported that 
dietary restrictions based on food sIgG4 are effective. Howev-
er, further well designed studies are required to confirm the 
clinical significance of sIgG4 measurement and sIgG4-based 
dietary restrictions in these diseases.
There are limitations in this study. First, an sIgG4 level less 
than 0.50 mg/L was considered a negative titer in this study. 
Since IgG production is associated with a normal immune re-
sponse to allergens,43 it is difficult to determine the clinical 
negative value, which may be quite different for each food or 
inhalant allergen. Therefore, 0.50 mg/L was considered as the 
threshold according to the detection limit of PROTIATM Specif-
ic IgG4®. Further studies are required to determine the nega-
tive reference values of sIgG4 in healthy subjects and patients. 
Second, some allergens, such as walnut and shrimp in qualita-
tive comparison and apple in quantitative comparison, 
showed relatively low agreement rates. This might be associat-
ed with the small sample size. There is also a possibility of kit 
inaccuracy. Considering that both assays were not compared 
for all measurable allergens, additional testing is needed. 
However, the most important inhalant allergens during immu-
notherapy, including house dust mites, birch, oak, ragweed, 
mugwort pollens, and Alternaria alternata spores, showed 
high agreement rates, and common culprit food allergens, in-
cluding egg white, casein, milk, crab, wheat, peanut, and 
peach, also showed high agreement rates. Therefore, we think 
that the potential applicability of PROTIATM Specific IgG4® for 
measuring sIgG4 in allergic diseases was adequately validated.
In conclusion, PROTIATM Specific IgG4®, a multiple sIgG4 
measurement assay, showed a high consistency with Immu-
noCAP® in quantifying sIgG4 levels. This assay is suitable for 
various clinical applications, especially in multiple allergen 
immunotherapy and food allergy patients with multiple cul-
prit allergens.
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